ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $688,432,000 | +82.9% | 4,476,100 | +49.2% | 10.82% | +65.1% |
| Q2 2021 | $376,470,000 | -7.5% | 3,000,000 | 0.0% | 6.55% | -6.8% |
| Q1 2021 | $406,830,000 | +105.2% | 3,000,000 | +93.5% | 7.03% | +105.7% |
| Q4 2020 | $198,307,000 | +30.5% | 1,550,000 | +14.8% | 3.42% | +58.2% |
| Q3 2020 | $151,916,000 | +53.3% | 1,350,000 | +29.8% | 2.16% | +10.2% |
| Q2 2020 | $99,081,000 | +28.2% | 1,040,000 | +20.9% | 1.96% | -24.9% |
| Q1 2020 | $77,288,000 | – | 860,000 | – | 2.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |